ProQR Therapeutics (PRQR) Total Debt Growth (1y) (2017 - 2026)
ProQR Therapeutics (PRQR) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | - |
| 10 | ProQR Therapeutics | 183.32 Mn | 91.03 Mn | - | 6.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.23% |
| Dec 31, 2025 | 6.33% |
| Sep 30, 2025 | 6.43% |
| Jun 30, 2025 | 6.54% |
| Mar 31, 2025 | 6.64% |
| Dec 31, 2024 | 6.76% |
| Sep 30, 2024 | -13.85% |
| Jun 30, 2024 | -31.69% |
| Mar 31, 2024 | -32.63% |
| Dec 31, 2023 | -36.61% |
| Sep 30, 2023 | -21.37% |
| Jun 30, 2023 | -85.56% |
| Mar 31, 2023 | -85.53% |
| Dec 31, 2022 | -84.64% |
| Sep 30, 2022 | -65.51% |
| Jun 30, 2022 | 142.75% |
| Dec 31, 2021 | 154.50% |
| Sep 30, 2021 | 10.14% |
| Jun 30, 2021 | 233.65% |
| Dec 31, 2020 | 32.73% |